In vitro, in tumour tissues of GC patients, AKT activation and PTEN loss were associated with increased resistance to multiple chemotherapeutic agents (5-FU, doxorubicin, mitomycin C and cisplatin) [44]. Here, PTEN is linked to gastric cancer.